These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22843427)

  • 21. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
    Alkan A; Yaşar A; Karcı E; Köksoy EB; Ürün M; Şenler FÇ; Ürün Y; Tuncay G; Ergün H; Akbulut H
    Support Care Cancer; 2017 Jan; 25(1):229-236. PubMed ID: 27619388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
    Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
    Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentially Inappropriate Prescribing in Disabled Older Patients with Chronic Diseases: A Screening Tool of Older Persons' Potentially Inappropriate Prescriptions versus Beers 2012 Criteria.
    Yang PJ; Lee YT; Tzeng SL; Lee HC; Tsai CF; Chen CC; Chen SC; Lee MC
    Med Princ Pract; 2015; 24(6):565-70. PubMed ID: 26279164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
    Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
    Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions.
    Green AR; Lee P; Reeve E; Wolff JL; Chen CCG; Kruzan R; Boyd CM
    J Am Board Fam Med; 2019; 32(3):383-391. PubMed ID: 31068402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor adherence to chronic obstructive pulmonary disease medications in primary care: Role of age, disease burden and polypharmacy.
    Vetrano DL; Bianchini E; Onder G; Cricelli I; Cricelli C; Bernabei R; Bettoncelli G; Lapi F
    Geriatr Gerontol Int; 2017 Dec; 17(12):2500-2506. PubMed ID: 28656664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults.
    Sugidono M; Lo M; Young R; Rosario K; Jung Y; Huang CY; Sheng Y; Huang LW; Olin RL
    Transplant Cell Ther; 2021 Apr; 27(4):344.e1-344.e5. PubMed ID: 33836888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inappropriate medication use and polypharmacy in end-stage cancer patients: Isn't it the family doctor's role to de-prescribe much earlier?
    Garfinkel D; Ilin N; Waller A; Torkan-Zilberstein A; Zilberstein N; Gueta I
    Int J Clin Pract; 2018 Apr; 72(4):e13061. PubMed ID: 29359381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication Discontinuation at the End of Life: A Questionnaire Study on Physicians' Experiences and Opinions.
    Geijteman ECT; Huisman BAA; Dees MK; Perez RSGM; van der Rijt CCD; van Zuylen L; van der Heide A
    J Palliat Med; 2018 Aug; 21(8):1166-1170. PubMed ID: 29668346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease.
    Detoni KB; Oliveira IV; Nascimento MM; Caux TR; Alves MR; Ramalho-de-Oliveira D
    Int J Clin Pharm; 2017 Feb; 39(1):95-103. PubMed ID: 27915426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients.
    Dhamane AD; Schwab P; Hopson S; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():115-122. PubMed ID: 28053521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro re nata prescribing in a population receiving palliative care: a prospective consecutive case note review.
    Russell BJ; Rowett D; Currow DC
    J Am Geriatr Soc; 2014 Sep; 62(9):1736-40. PubMed ID: 25124943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentially inappropriate medication in primary care at the end of life: a mixed-method study.
    Pype P; Mertens F; Helewaut F; D'Hulster B; De Sutter A
    Acta Clin Belg; 2018 Jun; 73(3):213-219. PubMed ID: 29199905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equal palliative care for patients with COPD? A nationwide register study.
    Henoch I; Strang P; Löfdahl CG; Ekberg-Jansson A
    Ups J Med Sci; 2019 Apr; 124(2):140-147. PubMed ID: 31012800
    [No Abstract]   [Full Text] [Related]  

  • 36. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review.
    Todd A; Husband A; Andrew I; Pearson SA; Lindsey L; Holmes H
    BMJ Support Palliat Care; 2017 Jun; 7(2):113-121. PubMed ID: 26733578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug consumption and futile medication prescribing in the last year of life: an observational study.
    Curtin D; O'Mahony D; Gallagher P
    Age Ageing; 2018 Sep; 47(5):749-753. PubMed ID: 29688246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [RATIONAL DE-PRESCRIBING TO TREAT POLYPHARMACY - COUNTERING THE FIRST IATROGENIC EPIDEMIC].
    Garfinkel D
    Harefuah; 2020 Sep; 159(9):683-688. PubMed ID: 32955812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?
    Todd A; Williamson S; Husband A; Baqir W; Mahony M
    Int J Clin Pharm; 2013 Apr; 35(2):181-4. PubMed ID: 23229875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.